{"id":"W2769634427","doi":"10.1177/2055217317743097","title":"A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Acorda Therapeutics","keywords":"Tolerability; Placebo; Medicine; Pharmacodynamics; Pharmacokinetics; Multiple sclerosis; Adverse effect; Cohort; Internal medicine; Dosing; Biomarker; Pharmacology; Gastroenterology; Immunology; Pathology; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001683126,0.001416242,0.002305019,0.0003295458,0.0006104535,0.0005177608,0.0005661039,0.001391495,0.003244949],"category_scores_gemma":[0.001279161,0.000696368,0.0008008525,0.0002053455,0.0007496861,0.0006182168,0.0003065217,0.001435136,0.0007286289],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003046028,"about_ca_system_score_gemma":0.000895439,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000514777,"about_ca_topic_score_gemma":0.001002755,"domain_scores_codex":[0.9993692,0.0002712531,0.00005731477,0.0001329513,0.00006603889,0.000103278],"domain_scores_gemma":[0.9992508,0.0001457101,0.0001709178,0.00006810672,0.00008597854,0.0002784336],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9263878,0.03433371,0.003483196,0.0004772459,0.0005129871,0.00007136647,0.0001792767,0.000161896,0.01443359,0.000027127,0.0003682184,0.01956342],"study_design_scores_gemma":[0.5889761,0.3933435,0.01463518,0.00002032909,0.0003841493,0.00005928486,0.00003894721,0.0001930556,0.00162749,0.00005544586,0.0006506535,0.00001583603],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964769,0.0008438994,0.0002403563,0.0001029145,0.00008974823,0.001586425,0.000216302,0.00003771426,0.0004056953],"genre_scores_gemma":[0.9936399,0.0006443214,0.0009847197,0.0004066722,0.0002375693,0.002340662,0.0002668609,0.000009032558,0.001470204],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003244949,"threshold_uncertainty_score":0.01085538,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2497445737129078,"score_gpt":0.4249105405719116,"score_spread":0.1751659668590039,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}